Maciej Banach

Dr Banach is a president of Polish Mother's Memorial Hospital - Research Institute (PMMHRI), head of the Cardiovascular Research Centre at University of Zielona Gora, Professor of Cardiology at the Medical University of Lodz (MUL) and PMMHRI, head of the Department of Hypertension at the Medical University of Lodz and professor in the Department of Nephrology, Hypertension and Family Medicine, chair of Nephrology and Hypertension, at the WAM University Hospital in Lodz, Poland.

Dr. Banach is former Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012); and head of Foreign Affairs Office at MUL (2012-2014).

He is a member of the Executive Committee of European Atherosclerosis Society, working as an advisor in matters related to European Union Relations/Contacts, and the International Atherosclerosis Society Regional Federation Executive Committee Member for Europe. He is a founder and head of the Polish Lipid Association and Lodz Chapter of Polish Society of Hypertension. He is the founder of the Lipid and Blood Pressure Meta-analysis Collaboration Group – consisting of more than 150 worldwide experts aimed to investigate the most important issues in the field of lipid disorders, hypertension, nutrition and cardiovascular risk, as well as the International Lipid Expert Panel, which has been founded to prepare recommendations in the area of preventive cardiology in the most debatable issues that have not been covered in the existing guidelines.

Dr Banach is a member of 2 largest worldwide databases – the Global Burden of Disease (University of Washington, Seattle) and Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC, Imperial, College of London). He is also founder and president of the foundation – Think-Tank “Innovation for Health,” which gathers 6 main health research institutes and over 40 medical business representatives in Poland. He is a visiting professor of University of Alabama at Birmingham, and University of Medicine and Pharmacy Victor Babes in Timisoara, Romania.

His main area of scientific interests concerns hypertension aspects (risk stratification, prehypertension, new biomarkers, optimal level of BP - J-curve phenomenon, pharmacotherapy/combined therapy, prevention, complications), lipid disorders (risk stratification, new biomarkers, diagnosis, rare diseases), dyslipidemia therapy (statins, new drugs, combined treatment) and new drugs in cardiovascular disease therapy.

Dr Banach has published more than 700 original articles, reviews, editorials and book chapters in the field of hypertension, dyslipidemia, cardiology, cardiac surgery, and risk stratification and has participated in nearly 100 clinical trials on these same subjects. In addition, he holds editorial roles on numerous scientific journals and has been the recipient of several prestigious European awards. Dr Banach is actively involved in many councils and associations that promote health and wellness.